Cancer decentralized clinical trials in the Veterans Health Administration
Cancer decentralized clinical trials can address barriers to participant enrollment, but not every clinical trial can be conducted in a decentralized manner. By sharing experiences regarding the conduct of cancer decentralized clinical trials in the VA, research sponsors, regulatory authorities, and other research groups can more readily and widely implement these trials.
Authors
- Sarah Bloemers
- Shannon Elam
- Holly Morris
- Daphne R. Friedman (ORCID: https://orcid.org/0000-0002-2938-5704)
- Michael J. Kelley (ORCID: https://orcid.org/0000-0001-9523-6080)
- Ashlyn Press (ORCID: https://orcid.org/0000-0001-7359-0505)
- Tiffany M. Stewart (ORCID: https://orcid.org/0000-0001-8669-9067)
- Zachary R. Burningham (ORCID: https://orcid.org/0000-0001-9545-6817)
- José Gil Martínez (ORCID: https://orcid.org/0000-0002-5812-8889)
- Perri Pepperman
- Jennifer Ordman
- Jacqueline Boreland
- Shelby Schoenborn
- C J Okeke
- B. Öberg
Institutions
- IBM (United States) (US)
- Duke University (US)
- University of Utah (US)
- Partners In Care (US)
- Prometheus Research (United States) (US)
- Durham VA Health Care System (US)
- Underground Systems (United States) (US)
- Department of Veterans Affairs (AU)
- George E. Wahlen Department of VA Medical Center (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1093/jnci/djaf279
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88